<DOC>
	<DOCNO>NCT00744341</DOCNO>
	<brief_summary>The purpose study determine efficacy safety IV SLV320 acute heart failure patient renal dysfunction .</brief_summary>
	<brief_title>Safety Efficacy Study Evaluate Effect SLV320 Renal Function Patients With Worsening Heart Failure</brief_title>
	<detailed_description>The purpose study determine efficacy safety IV SLV320 acute heart failure patient renal dysfunction .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Inclusion Criteria Renal dysfunction define estimate eGFR 2080 mL/min ; history systolic diastolic chronic heart failure least 14 day duration loop diuretic therapy prescribe ; clinical evidence volume overload ; BNP â‰¥ 500 pg/mL NTproBNP &gt; 2000 pg/mL ; hospitalization . Exclusion Criteria Have low output syndrome , define need treatment I.V . inotropes vasopressor ; Need mechanical ventilation ; Have significant stenotic valvular disease ( severe aortic mitral stenosis ) ; Have myocardial infarction hemodynamically destabilizing significant arrythmias ( ventricular tachycardia , bradyarrythmias slow ventricular rate [ &lt; 45 bpm ] atrial fibrillation/flutter rapid ventricular response &gt; 120 bpm ) , electrocardiographic evidence 2nd degree heart block ( Mobitz Type II ) 3rd degree AVblock absence pacemaker , within 30 day screen ; Have acute myocarditis hypertrophic obstructive , restrictive , constrictive cardiomyopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>SLV320 ; Acute Decompensated Heart Failure ( ADHF ) ; chronic heart failure ; renal failure ; I.V . dos ; hospitalization</keyword>
</DOC>